Diphtheria toxin-granulocyte-macrophage colony-stimulating factor

Drug Profile

Diphtheria toxin-granulocyte-macrophage colony-stimulating factor

Alternative Names: DT-GMCSF

Latest Information Update: 01 May 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Class Biological toxins; Drug conjugates; Granulocyte-macrophage colony-stimulating factors
  • Mechanism of Action Immunosuppressants; Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Acute lymphoblastic leukaemia

Most Recent Events

  • 23 Mar 1999 Preclinical study added to pharmacodynamics, pharmacokinetics and adverse events sections
  • 26 Nov 1998 New profile
  • 26 Nov 1998 Preclinical development for Acute lymphoblastic leukaemia in Netherlands (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top